ERIN MORABITO: Open Payments
NPI 1386192953 · AKRON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,316 in 140 payments from 21 companies in 2025. Trend: 2023 $466 · 2024 $2,178 · 2025 $2,316
Food & beverage: $2,204Education: $111
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 14 | $359 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 16 | $293 |
| Teva Pharmaceuticals USA, Inc. | 11 | $229 |
| Indivior Inc. | 24 | $217 |
| Janssen Pharmaceuticals, Inc | 9 | $185 |
| Axsome Therapeutics, Inc. | 12 | $170 |
| Otsuka America Pharmaceutical, Inc. | 10 | $158 |
| Lundbeck LLC | 10 | $140 |
| Alkermes, Inc. | 10 | $135 |
| Braeburn Inc. | 4 | $74 |
Products named: CAPLYTA, FANAPT, SUBLOCADE, REXULTI, Auvelity, ARISTADA, ABILIFY MAINTENA, SPRAVATO.
Industry payments across OH — which companies pay providers there.
